Imed 2013

International Meeting on Emerging
Diseases and Surveillance
Vienna, Austria • February 15 –18, 2013

Co-sponsored by
ProMED-mail, the Program for Monitoring Emerging Diseases
EcoHealth Alliance
European Centre for Disease Prevention and Control ( ECDC )
European Society of Clinical Microbiology and Infectious Diseases ( ESCMID)
Food and Agriculture Organization of the United Nations ( FAO)
HealthMap
Skoll Global Threats Fund (SGTF)
World Organisation for Animal Health (OIE )

Organized by the International Society for Infectious Diseases

FINAL PROGRAM

16th International Congress
on Infectious Diseases
Cape Town • SouTh afriCa
april 2~5, 2014

organized by the

international Society for infectious Diseases

in collaboration with the
federation of infectious Diseases Societies of Southern africa

2013

IMED
International Meeting
on E m e r g i n g D i s e a s e s
and Surveillance

Co-sponsored by
ProMED-mail, the Program for Monitoring Emerging Diseases
EcoHealth Alliance
European Centre for Disease Prevention and Control ( ECDC )
European Society of Clinical Microbiology and Infectious Diseases ( ESCMID)
Food and Agriculture Organization of the United Nations ( FAO)
HealthMap
World Organisation for Animal Health (OIE )

Organized by the International Society for Infectious Diseases

FINAL PROGRAM

Table of Contents
International Meeting on Emerging Diseases and Surveillance 2 013

Welcome. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Committees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
General Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Floorplans | Hilton Vienna . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Program-at-a-Glance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
.
Scientific Program. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Friday, February 15, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Saturday, February 16, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Sunday, February 17, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Monday, February 18, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Poster Presentations I • Saturday, February 16, 2013. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Poster Presentations II • Sunday, February 17, 2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Abstracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Friday, February 15, 2013
Session 01: Science and Sensationalism, Emerging Infections and Emergency!. . . . . . . . . . . . . . . . . . . . 37
Session 02: Ecology, Biodiversity, Climate and Emerging Infectious Disease . . . . . . . . . . . . . . . . . . . . . . 37
Session 03: Emerging Infectious Diseases and the Hajj. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Saturday, February 16, 2013
Session 04: Emerging Disease Prevention. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Session 05: Oral Presentations: One Health in Action . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Session 06: Emerging Fungal Diseases and Species Extinction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Session 07: Of Bats and Men: Nipah and Other Infections. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
.
Session 08: Oral Presentations: ‘Contagion’: Contemporary Viral Pathogens. . . . . . . . . . . . . . . . . . . . 46 .
Session 09: Emerging Disease Mysteries. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Session 10: Vectorborne Diseases in Humans and Animals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
Sunday, February 17, 2013
Session 11: Neglected Zoonotic Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Session 12: Oral Presentations: Infection, Detection, and Protection: Adventures in Epidemiology. . 52 .
Session 13: Global Approach to the Control of Foot and Mouth Disease. . . . . . . . . . . . . . . . . . . . . . 56 .
Session 14: Cutting Edge Diagnostics for the Detection of Novel and Neglected Diseases. . . . . . . . 56
Session 15: Updates from ProMED (Panel Discussion). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
Session 16: Disease Surveillance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
Session 17: Oral Presentations: Hot Topics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
Monday, February 18, 2013
Session 18: Economics of Emerging Infectious Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
Session 19: Diseases Without Borders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
Session 20: Big Data, Industry and Disease Surveillance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
Poster Presentations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
Saturday, February 16, 2013
Session 21: Poster Presentations I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
Antimicrobial Resistance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
Bioterrorism and Biological Warfare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
Climate Change and Ecological Factors in Disease Emergence. . . . . . . . . . . . . . . . . . . . . . . . . . 77
Diseases at the Interface of Humans, Wildlife and Other Animals. . . . . . . . . . . . . . . . . . . . . . . 80 .
Diseases of Animals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
Foodborne and Waterborne Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
Infections of Public Health Significance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Infections Related to Travel and Migration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
Innovations in Diagnostic Tests for Emerging Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
New Pathogen Discovery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
Sunday, February 17, 2013
Session 22: Poster Presentations II. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
Influenza and Other Respiratory Infections. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
New Approaches to Outbreak Surveillance and Monitoring. . . . . . . . . . . . . . . . . . . . . . . . . . . 136
New, Emerging and Neglected Zoonotic Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
Outbreak Modeling. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
Outbreak Response and Control. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
.
Public Communication of Outbreaks and Emerging Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . 168
Sociopolitical Factors in Disease Emergence. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
Vaccines and Emergence of Vaccine Preventable Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
Vectorborne Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
Index of Authors and Co-Authors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191

ii
IMED 2013

Welcome

Welcome to the great city of Vienna and the fourth International Meeting on Emerging Diseases
and Surveillance, IMED 2013. Now established as a fixture for those whose work deals with
threats from infectious agents, IMED 2013 will once again bring leading scientists, clinicians and
policy makers together to present new knowledge and breakthroughs and discuss how to
discover, detect, understand, prevent and respond to outbreaks of emerging pathogens.

Since the last IMED, newly emerged diseases and outbreaks of familiar ones have continued to
challenge us and keep us vigilant. While the influenza pandemic that began in 2009 has quieted,
an early and severe flu season has occurred in the Northern hemisphere and eruptions of
H5N1 highly pathogenic avian influenza in poultry, wild birds and humans continue to occur.
A new strain of H3N2 has transmitted from pigs to humans and, at least occasionally, from
person to person.. A novel coronavirus has caused severe human disease in several countries
and the newly discovered Schmallenberg virus, has emerged in livestock in Northern Europe.
Diseases at the human-wildlife interface ranging from rabies to plague to Nipah virus continue
to draw our attention. Growing resistance by pathogens to all types of therapeutic agents raises
fundamental obstacles to our ability to respond to outbreaks and pandemics. The threat of
intentional use of biological agents for nefarious purposes remains as real as ever.

Since its inception, IMED has been a summit that unifies our approach to pathogens in the
broadest ecological context. Drawing together human and veterinary health specialists, IMED
serves as a true One Health forum where those working in diverse specialties and diverse
regions can meet, discuss, present and challenge one another with findings and new ideas.
This year, over 700 abstracts were submitted, a record number. A selection of the best among
these will be presented in two poster sessions and four oral sessions.

A meeting of this scope could not occur without the help of many, and I particularly want to
thank our co-sponsors for making IMED possible: EcoHealth Alliance, the European Centers
for Disease Control and Prevention (ECDC), the European Society of Clinical Microbiology
and Infectious Diseases (ESCMID), HealthMap, the Skoll Global Threats Fund (SGTF) and the
World Organisation for Animal Health (OIE). We also acknowledge the generous technical con-
tribution of the Food and Agriculture Organization of the United Nations (FAO) and the sup-
port from the Vienna Convention Bureau, the Mayor of Vienna and Austrian Airlines.

While pathogens emerge and mutate, our methodology for detection, surveillance, prevention,
control, and treatment also continue to evolve. New approaches to the uses of social media
and data mining, novel laboratory methods, rapid point-of-care diagnostics, risk communication,
political and societal responses to outbreaks have all seen innovation and change that will be
explored at IMED 2013.
Thank you for your participation.

Sincerely,

Larry MADOFF
Chair, Scientific Program Committee
Editor, ProMED-mail, International Society for Infectious Diseases
Boston, USA

1
IMED 2013

Committees

Scientific Program Committee
Larry Madoff, Boston, MA, USA – Chair
Jacques Acar, Paris, France
Yin Myo Aye, Bangkok, Thailand
Daniel Beltrán-Alcrudo, Rome, Italy
Timothy Brewer, Montreal, Canada
John Brownstein, Boston, MA, USA
Ilaria Capua, Padova, Italy
Giuseppe Cornaglia, Verona, Italy
Sidi Coulibaly, Ouagadougou, Burkina Faso
Benson Estambale, Nairobi, Kenya
David Fisman, Toronto, Canada
Antoine Flahault, Paris, France
Johann Giesecke, Stockholm, Sweden
David Heymann, London, United Kingdom
Jim Hughes, Atlanta, GA, USA
Damien Joly, Nanaimo, BC, Canada
William Karesh, New York, NY, USA
Keith Klugman, Atlanta, GA, USA
Daniel Lucey, Washington, DC, USA
Nina Marano, Nairobi, Kenya
Abla Mawadeku, Ottawa, Canada
Kazuaki Miyagishima, Paris, France
Norbert Nowotny, Vienna, Austria & Muscat, Oman
Philip Polgreen, Iowa City, IA, USA
Co-Sponsors
Marjorie Pollack, New York, NY, USA
Natalia Psenichnaya, Rostov-on-Don, Russia
Arnon Shimshony, Jerusalem, Israel
Mark Smolinski, San Francisco, CA, USA
Eric Summers, Boston, MA., USA
Jaime Torres, Caracas, Venezuela
Jack Woodall, Rio de Janeiro, Brazil

Co-Sponsors
* ProMED-mail, the Program for Monitoring Emerging Diseases
EcoHealth Alliance
European Centre for Disease Prevention and Control (ECDC)
European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Food and Agriculture Organization of the United Nations ( FAO)*
HealthMap
World Organisation for Animal Health (OIE)
* With a technical contribution from the Food and Agriculture Organization of the United Nations.
2
IMED 2013

Committees

Cooperating Organizations
Austrian Agency for Health and Food Safety (AGES)
Austrian Federal Ministry of Health
Austrian Society for Infectious Diseases (ÖEGIT)
Austrian Society of Hygiene, Microbiology and Preventive Medicine (ÖGHMP)
Austrian Society of Tropical Medicine and Parasitology (ÖGTP)
International Society for Infectious Diseases (ISID)
International Society for Disease Surveillance (ISDS)
University of Veterinary Medicine Vienna – (Vetmeduni Vienna)

Contributors
Austrian Airlines
City of Vienna
EcoHealth Alliance
International Society for Infectious Diseases (ISID)
Vienna Hilton Am Stadtpark
Vienna Convention Bureau

Exhibitors
Amplex BioSystems
European Centre for Disease Prevention and Control (ECDC)
Food and Agriculture Organization of the United Nations (FAO)
International Society of Travel Medicine (ISTM)
World Organisation for Animal Health (OIE)
R-Biopharm
We invite you to visit the Exibits in the
Pre-Function Area on the Ground Level.

Organizer & Conference Office
International Society for Infectious Diseases
9 Babcock Street, Unit 3, Brookline, MA 02446, USA
phone: (617) 277-0551 • fax: (617) 278-9113
email: info@isid.org
web: http://www.isid.org • http://imed.isid.org

Exhibition Office
Media Plan
Freyung 6
1010 Vienna, Austria
Phone: (+43 1) 536 63 0
Fax: (+43 1) 535 60 16
Email: mp@media.co.at

3
IMED 2013

G eneral I nformation

Opening Hours of the Registration and Information Desk
Friday, February 15, 2013 11:00 – 19:00hrs
Saturday, February 16, 2013 08:00 – 18:00hrs
Sunday, February 17, 2013 08:00 – 18:00hrs
Monday, February 18, 2013 08:00 – 12:00hrs
Congress Venue
Hilton Vienna • Am Stadtpark • 1030 Vienna • Tel: +43 1 717 000 • http://www.hilton.com
Registration Fees
Participants: EUR 495.00 Students: EUR 275.00
Social Program
The Welcome Reception will be held on Friday, February 15 from 17:30 to 19:00hrs
at the Hilton Hotel Vienna on the Gallery (Upper Level).
The Mayor’s Reception will take place on Sunday, February 17 at 20:00hrs at the Vienna City
Hall (entrance: Lichtenfelsgasse, 1010 Vienna). An invitation card is needed to gain access to
this reception.The price is EUR 20,00 per person. Onsite registration is subject to availability.
For both functions business attire is appropriate.
Badges
Please wear your name badge at all times during the conference in order to gain
access to the scientific program and all conference functions.
Internet Access
The Hilton provides free internet access in the main hotel lobby. WiFi access in the sleeping
rooms and conference area is available for a special conference fee if you present your IMED
name badge. Tickets can be purchased from the reception desk on the ground level
(EUR 10 for 24 hours).
CME
The International Meeting on Emerging Diseases and Surveillance –IMED 2013 is accredited by
the European Accreditation Council for Continuing Medical Education (EACCME) to provide
the following CME activity for medical specialists. The EACCME is an institution of the European
Union of Medical Specialists (UEMS), www.uems.net.
The International Meeting on Emerging Diseases and Surveillance –IMED 2013 is designated
for a maximum of, or up to 17 hours of European external CME credits. Each medical specialist
should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American
Medical Association, physicians may convert EACCME credits to an equivalent number of
AMA PRA Category 1 Credits.™ Information on the process to convert EACCME credit to
AMA credit can be found at www.ama-assn.org/go/internationalcme.
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for
ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined
by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons
of Canada.
RACE (Veterinary CE)
The American Association of Veterinary State Boards RACE committee has reviewed and ap-
proved IMED 2013 as meeting the Standards adopted by the AAVSB, (maximum CME for one
veterinarian: 16.5). This course meets the requirements for hours of continuing education in
jurisdictions which recognize AAVSB RACE approval; however, participants should be aware that
some boards have limitations on the number of hours accepted in certain categories and/or
restrictions on certain methods of delivery.
All CME forms are included in the congress bag. Please complete and return forms to the ISID
after the conference is over as indicated on the form.
4
IMED 2013

G eneral I nformation

Poster Presentations
Poster presentations will be held on Saturday, February 16 and Sunday, February 17
from 11.45 to 13.15hrs. During this period all presenters must be available for
discussion at their posters.

Set-up for Poster Presentations I:
Saturday, February 16 from 08:00 to 10:30hrs
Removal: Saturday, February 16 from 16:30 to 18:00hrs

Set-up for Poster Presentations II:
Sunday, February 17 from 08:00 to 10:30hrs
Removal: Sunday, February 17 from 16:30 to 18:00hrs

Poster Areas (Upper Level)
Saturday, February 16, 2013 / Poster Presentations I
11:45–13:15
Room Bruckner/Mahler/Brahms / Upper Level:
Abstract Number Topic
21.001 – 21.032 Antimicrobial resistance
21.033 – 21.034 Bioterrorism and biological warfare
21.035 – 21.045 Climate change and ecological factors in disease emergence
21.046 – 21.079 Diseases at the interface of humans, wildlife and other animals
21.080 – 21.095 Diseases of animals
21.096 – 21.114 Foodborne and waterborne diseases
21.115 – 21.127 Infections of public health significance

Klimt Ballroom I / Upper Level:
21.128 – 21.169 Infections of public health significance (continued)
21.170 – 21.180 Infections related to travel and migration
21.181 – 21.184 Innovations in diagnostic tests for emerging diseases
21.185 – 21.187 New pathogen discovery

Sunday, February 17, 2013 / Poster Presentations II
11:45–13:15
Room Bruckner/Mahler/Brahms / Upper Level:
22..001 – 22.027 Influenza and other respiratory infections
22..028 – 22.060 New approaches to outbreak surveillance and monitoring
22..061 – 22.093 New, emerging, and neglected zoonotic diseases
22..094 – 22.097 Outbreak modeling
22..098 – 22.116 Outbreak response and control
22.117 – 22.118 Public communication of outbreaks and emerging diseases
22.119 – 22.125 Sociopolitical factors in disease emergence

Klimt Ballroom I / Upper Level:
22.126 – 22.138 Vaccines and emergence of vaccine preventable diseases
22.139 – 22.185 Vectorborne diseases
5
IMED 2013

Floorplans • H ilton A m Stadtpark Vienna

GROUND LEVEL

Park Congress
Pre-Function
REGISTRATION Area
PLENARY
EXHIBITION
HALL
COFFEE

FIRST LEVEL ProMED-mail Meeting (Mon.)

POSTERS BREAK-OUT SESSIONS

Brahms
Klimt Klimt
Ballroom Ballroom
1 2&3
Gallery

Gallery

POSTERS Mahler

Bruckner
Gallery COFFEE

Schonberg

6
IMED 2013

Program - at- a-G lance

Time Friday, February 15, 2013 Room
11:00–19:00 Registration and Information Desk Foyer/Park Congress/Ground Level
14:00–14:20 Welcome & Opening Park Congress/Ground Level
14:20–15:00 Session I: Plenary Lecture: Science and Sensationalism, Park Congress/Ground Level
Emerging Infections and Emergency!
15:00–16:30 Session 2: Plenary Lecture: Ecology, Biodiversity, Climate and Park Congress/Ground Level
Emerging Infectious Disease
16:30–17:15 Session 3: Plenary Lecture: Emerging Infectious Diseases Park Congress/Ground Level
and the Hajj
17:30–19:00 Welcome: Cocktail Reception Gallery/Upper Level
Time Saturday, February 16, 2013 Room
08:30–10:30 2 Break-out Sessions:
Session 4: Emerging Disease Prevention Park Congress/Ground Level
Session 5: Oral Presentations: One Health in Action Klimt Ballroom 2&3/Upper Level
10:30–11:00 Coffee Break Ground Level and Upper Level
11:00–11:45 Session 6: Plenary Lecture: Emerging Fungal Diseases and Park Congress/Ground Level
Species Extinction
11:45–13:15 Poster Presentations I (Session 21) Bruckner/Mahler/Brahms/Upper Level
and Klimt Ballroom1/Upper Level
Session 7: Of Bats and Men: Nipah and Other Infections Park Congress/Ground Level
Session 8: Oral Presentations: ‘Contagion’: Contemporary Klimt Ballroom 2&3/Upper Level
Viral Pathogens
Session 9: Emerging Disease Mysteries Park Congress/Ground Level
Session 10: Vectorborne Diseases in Humans and Animals Klimt Ballroom 2&3/Upper Level
Time Sunday, February 17, 2013 Room
Session 11: Neglected Zoonotic Diseases Park Congress/Ground Level
Session 12: Oral Presentations: Infection, Detection, and Klimt Ballroom 2&3/Upper Level
Protection: Adventures in Epidemiology
11:00–11:45 Session 13: Plenary Lecture: Global Approach to the Park Congress/Ground Level
Control of Foot and Mouth Disease
11:45–13:15 Poster Presentations II (Session 22) Bruckner/Mahler/Brahms/Upper Level
and Klimt Ballroom1/Upper Level
Session 14: Cutting Edge Diagnostics for the Detection of Park Congress/Ground Level
Novel and Neglected Diseases
Session 15: Updates from ProMED (Panel Discussion) Klimt Ballroom 2&3/Upper Level
Session 16: Disease Surveillance Park Congress/Ground Level
Session 17: Oral Presentations: Hot Topics Klimt Ballroom 2&3/Upper Level
20:00–22:00 Mayor’s Reception Vienna City Hall (Entrance: Liechtenfelsgasse)
Time Monday, February 18, 2013 Room
Session 18: Economics of Emerging Infectious Diseases Park Congress/Ground Level
Session 19: Diseases without Borders Klimt Ballroom 2&3/Upper Level
11:00–11:45 Session 20: Plenary Lecture: Big Data, Industry and Park Congress/Ground Level
Disease Surveillance

The program is subject to changes! 7
IMED 2013

S cientific Program FRIDAY • FEBRUARY 15, 2013

Opening Session Session 02
Room: Park Congress 14:00–14:20 Plenar y Lectures
Ground Level Friday, February 15, 2013 Ecology, Biodiversity, Climate and
February 15, 2013

Welcome by the President of the Emerging Infectious Diseases
International Society for Infectious Diseases (ISID) Co-Chairs: William Karesh, USA
Keith Klugman Juan Lubroth, Italy
Atlanta, GA (USA)
Room: Park Congress 15:00–16:30
•

Welcome to Vienna Ground Level Friday, February 15, 2013
FRIDAY

Norbert Nowotny
02.001 Different views of looking at biodiversity
Vienna (Austria)
and health
W. Karesh
Official Opening of the Conference
New York, NY (USA)
Pamela Rendl-Wagner, Director General,
Public Health, Austria 02.002 Concerns of the biodiversity community for
Vienna (Austria) integrating health
D. Coates
Welcome to IMED 2013 Montreal (Canada)
Larry Madoff 02.003 Climate change, biodiversity loss, desertification
Boston, MA (USA) and human health - the WHO Perspective
D. Campbell-Lendrum
Geneva (Switzerland)
02.004 Wildlife trade and emerging diseases- Impacts
on biodiversity and health
K. Smith
New York, NY (USA)
Co-sponsored by EcoHealth Alliance

Session 03
Plenar y Lecture
Emerging Infectious Diseases
and the Hajj
Chair: Marjorie Pollack, USA

Session 01 Room: Park Congress 16:30–17:15
Ground Level Friday, February 15, 2013
Plenar y Lecture
Science and Sensationalism, Emerging 03.001 Emerging infectious diseases and the Hajj
Z. Memish
Infections and Emergency! Riyadh (Saudi Arabia)
Chair: Keith Klugman, USA
Room: Park Congress 14:20–15:00 Welcome Cocktail Reception
Ground Level Friday, February 15, 2013
Gallery 17:30–19:00
01.001 Science and sensationalism, emerging infections Upper Level Friday, February 15, 2013
and emergency!
A. Schuchat
Atlanta, GA (USA)

8
IMED 2013

S cientific Program SATURDAY • FEBRUARY 16, 2013

05.004 Monitoring of influenza virus in pigs and
Session 04 humans in Switzerland
Emerging Disease Prevention M. Engels1, Y. Thomas2, E. Fuchsini3, R. Born4,
Co-Chairs: Julio Pinto, Italy S. Bruhn4
Nina Marano, Kenya
1
Zurich (Switzerland), 2Geneva (Switzerland),
3
Sempbach (Switzerland), 4Berne (Switzerland)
05.005 Coxiella burnetti seroprevalence and risk factors
Ground Level Saturday, February 16, 2013
in dairy cattle farmers and farm residents in the
04.001 Introduction to FAO's role in emerging disease Netherlands
prevention J. Hautvast1, N. Schotten1, B. Schimmer 2,
J. Lubroth P. Schneeberger 3, P. Vellema4, Y. van Duynhoven2
Rome (Italy)
1
Nijmegen (Netherlands), 2Bilthoven
(Netherlands), 3Den Bosch (Netherlands),
04.002 Strengthening laboratory networks and strategies 4
Deventer (Netherlands)
to meet the challenges of emerging and
transboundary animal diseases (TADs) threats 05.006 High colonization rate of farmers, their relatives
F. Claes and employees at pig farms with emerging
Clostridium difficile PCR ribotype 078

SATURDAY
Rome (Italy)
04.003 Innovation to fill the gaps in disease surveillance: E. Keessen1, M. Hensgens2, M. Bos1, W. Dohmen1,
Participatory surveillance, applied technologies J. Wagenaar3, D. Heederik1, E. Kuijper2, L. Lipman1
for better understanding and reporting
1
Utrecht (Netherlands), 2Leiden (Netherlands),
3
Netherland (Netherlands)

•
J. Pinto

February 16, 2013
Rome (Italy) 05.007 West Nile Disease in Italy: Animal surveillance
04.004 Dealing with the biocomplexity of emerging activities as an early warning system for the
infectious diseases (EIDs): An ecosystem health prevention and control of the infection in humans
approach R. Bruno, D. Di Sabatino, A. Carvelli, F. De
D. Beltrán-Alcrudo Massis, P. Calistri
Rome (Italy) Teramo (Italy)
With a technical contribution from the Food and Agriculture 05.008 Sylvatic origin and geographic spread of
Organization of the United Nations. St. Louis encephalitis virus
A. Kopp1, T. Gillespie2, D. Hobelsberger3,
A. Estrada4, I. Eckerle1, M. Mueller1,
Session 05 L. Podsiadlowski5, F. Leendertz3,
Oral Presentations C. Drosten1, S. Junglen1
1
Bonn (Germany), 2Atlanta, GA (USA), 3Berlin
One Health in Action (Germany), 4Mexico City (Mexico),
Co-Chairs: Tim Brewer, USA 5
Bonn (Germany)
Natalia Pshenichnaya, Russian Federation
05.009 Considerable relation with foot-and-mouth
Room: Klimt Ballroom 2&3 8:30–10:30 disease (FMD) infection in Japan, 2010; Traffic
Upper Level Saturday, February 16, 2013 roads and pig farming area
R. Ushijima
05.001 Evaluating long-term behavior change resulting Miyazaki (Japan)
from an intervention to prevent Nipah virus
transmission from bats to humans in Bangladesh 05.010 West Nile Virus in Canada: 2002–2012
R. Sultana, U. K. Mondal, J. Abedin, M. J. Hossain, H. Zheng, A. S. Yasseen, P. A. Buck, F. Welsh,
M. A. Y. Sharker, N. A. Rimi, E. Gurley, N. Nahar, M. Raizenne
S. P. Luby Ottawa, ON (Canada)
Dhaka (Bangladesh) 05.011 Zoonotic diseases monitored by Brazil National
05.002 Characterizing high risk disease transmission IHR Focal Point from March 2006 to June 2012
interfaces in the global pursuit of emerging M. É. Santos, S. Lopes Dias, E. T. Masuda,
zoonotic diseases P. Pereira Vasconcelos de Oliveira, G. S. Dimech
C. K. Johnson1, T. W. Smiley1, T. Goldstein1, Brasilia (Brazil)
W. Karesh2, D. Joly3, P. Daszak2, J. Mazet1
1
Davis, CA (USA), 2New York, NY (USA),
3
Nanaimo, BC (Canada)
05.003 Rabies control in Bali: A “one health” approach
E. Russell, F. Abson
9
London (United Kingdom)
IMED 2013


Coffee Break Session 08
Ground Level 10:30–11:00 Oral Presentations
and Upper Level Saturday, February 16, 2013
‘Contagion’: Contemporary
Viral Pathogens
Session 06 Co-Chairs: Sidi Coulibaly, Burkina Faso
Stuart Handysides, United Kingdom
Plenar y Lecture
Room: Klimt Ballroom 2&3 14:30–16:00
Emerging Fungal Threats to Animal, Upper Level Saturday, February 16, 2013
Plant and Ecosystem Health
Chair: John Brownstein, USA 08.001 Hepatitis E virus antigen detection:
An early diagnostic marker
Room: Park Congress 11:00–11:45 R. Ratho, M. Majumdar, M. P. Singh, Y. Chawla
Ground Level Saturday, February 16, 2013 Chandigarh (India)

06.001 Emerging fungal threats to animal, plant 08.002 Evolution of H3N2 influenza viruses from
February 16, 2013

and ecosystem health the Philippines
M. Fisher B. C. Torres1, Y. C. F. Su2, M. S. H. Chua2, H. Guo2,
London (United Kingdom) A. K. Cruz1, D. C. Klinzing1, G. J. D. Smith2, F. F.
Natividad1
1
Quezon City (Philippines), 2Singapore
Poster Presentations I (Session 21) (Singapore)
•

08.003 Influence of the viral membrane, inherited from
SATURDAY

Saturday, February 16, 2013 11:45–13:15
different host species, on survival of influenza A
Bruckner/Mahler/Brahms - Upper Level viruses in water
and Klimt Ballroom 1 - Upper Level S. Shigematsu, A. Dublineau, L. I. O. Sawoo,
Sessions 21.001–21.187 (see pages 65–126) I. Leclercq, J.-C. Manuguerra
Paris (France)
08.004 Investigation of deaths due by Influenza A(H1N1)
Session 07 pdm09 in Southern Brazil, July-August, 2012
Of Bats and Men: Nipah and R. Soletti1, W. Oliveira1, F. Costa1, F. de Paula1,
R. Moreira1, L. Garay2, M. Bercini2, E. M. Macario1,
Other Infections C. N. Igansi1, W. Araújo1
Co-Chairs: Daniel Lucey, USA 1
Brasília (Brazil), 2Porto Alegre(Brazil)
Damien Joly, Canada
08.005 Enhancing the specificity of surveillance case
Room: Park Congress 14:30–16:00 detection of Monkeypox in Democratic Republic
Ground Level Saturday, February 16, 2013 of Congo (DRC).
L. U. Osadebe1, A. McCollum1, R. S. Lushima2,
07.001 Understanding the ecology of Nipah virus in E. Pukuta2, S. Karhemere2, J. Kabamba2, B. Nguete2,
frugivorous bats in Bangladesh I. Damon1, J. J. Muyembe2, M. Reynolds1
J. H. Epstein 1
Atlanta, GA (USA), 2Kinshasa (Congo,
New York, NY (USA) Democratic Republic of)
07.002 From bats to human-to-human transmission 08.006 First autochthonous outbreak of dengue in the
of Nipah virus in Bangladesh island of Madeira, October 2012: A challenge for
H. S. Sazzad the European Union Region
Dhaka (Bangladesh) P.Vasconcelos1, H. Zeller2, C. Abreu Santos1,
07.003 “One Health” Surveillance for Nipah virus B. Sudre2, J. Gomes Dias2, J. Jansa2, A. C. Silva3,
in Thailand A. Nunes3, A. Leça1, K. Mansinho1
S. Wacharapluesadee
1
Lisbon (Portugal), 2Stockholm (Sweden),
Bangkok (Thailand)
3
Funchal (Portugal)

10
IMED 2013


08.007 Dengue fever outbreak in North Eastern 09.003 EV71 virus
Kenya, 2011 P. Chua
M. O. Obonyo, W. Arvelo, V. O. Ofula, Singapore (Singapore)
A. Fidhow, B. Fields, R. Sang, E. Wurapa, 09.004 Ebola and Marburg viruses emergence
K. Njenga, J. Montgomery at the human-animal interface
Nairobi (Kenya) P. Formenty
08.008 Evaluation of innate immune response in Geneva (Switzerland)
acute and fulminant hepatitis E
M. Majumdar, R. Ratho, Y. Chawla, M. P. Singh
Chandigarh (India) Session 10
Vectorborne Diseases in Humans
Coffee Break and Animals
Ground Level 16:00–16:30 Co-Chairs: Arnon Shimshony, Israel
and Upper Level Saturday, February 16, 2013 Norbert Nowotny, Oman

SATURDAY
Upper Level Saturday, February 16, 2013
Session 09
10.001 A novel orthobunyavirus in
Emerging Disease Mysteries European livestock: the emergence
Co-Chairs: Joseph Wamala, Uganda of Schmallenberg virus

•
February 16, 2013
Leo Liu, USA M. Beer
Room: Park Congress 16:30–18:00 Greifswald-Insel Riems (Germany)
Ground Level Saturday, February 16, 2013 10.002 Emerging zoonotic vector-borne
diseases in Europe
09.001 Magnitude and distribution of Nodding N. Nowotny
Syndrome in Northern Uganda Muscat (Oman)
J. F. Wamala
Kampala (Uganda) 10.003 Emerging insect vector-borne
animal diseases in the eastern
09.002 Nodding Syndrome: An emerging epilepsy
Mediterranean
disorder of sub-Saharan Africa
E. Klement
A. Winkler
Rehovot (Israel)
Munich (Germany)

ProMED
mail
Program for Monitoring Emerging Diseases

Subscribe for free email updates
about threats to human, animal, and
food plant health around the world.

www.promedmail.org
Sponsored by the
International Society for
Infectious Diseases

ProMED Postcard 4 x 6 V6 V1.indd 1 5/19/11 11:22 AM
11
IMED 2013

S cientific Program SUNDAY • FEBRUARY 17, 2013

Session 11 12.005 Characterizing zoonotic disease outbreaks
in the United States
Neglected Zoonotic Diseases H. Allen
Co-Chairs: Matt Levison, USA McLean, VA (USA)
Tam Garland, USA
12.006 Estimating global mortality associated with
Room: Park Congress 08:30–10:30 the influenza A H1N1 pandemic in 2009: the
Ground Level Sunday, February 17, 2013 WHO Global Pandemic Mortality Assessment
(GLaMOR) project
11.001 The economic and health burden of neglected L. Simonsen1, P. Spreeuwenberg2, R. Lustig3,
zoonotic diseases R. J. Talyor3, D. M. Fleming4, M. Kroneman2,
P.Torgerson L. W. Kim3, M. D. Van Kerkhove 5, A. W. Mounts6,
Zurich (Switzerland) J. W. Paget2
11.002 Rabies: the path to elimination 1
Washington DC, DC (USA),
A. L. Willingham 2
Utrecht (Netherlands), 3Bethesda, DC (USA),
Geneva (Switzerland) 4
Birmingham (United Kingdom), 5London
11.003 Echinococcosis: endemic and re-emergent (United Kingdom), 6Geneva (Switzerland)
P. Craig 12.007 Domestic birds as surveillance systems for
Salford (United Kingdom) monitoring West Nile virus lineage 2 enzootic
11.004 Implementing the roadmap to combat circulation: three years of experience in Greece
Cysticercosis C. I. Dovas1, S. C. Chaintoutis1,
A. L. Willingham A. Chaskopoulou1, S. Gewehr1,
Geneva (Switzerland) M. Papanastassopoulou1, S. Mourelatos1,
S. Zientara2, S. Lecollinet2, K. Danis3,
T. Panagiotopoulos3
Session 12 1
Thessaloniki (Greece), 2Maisons-Alfort (France),
Oral Presentations
3
Athens (Greece)
12.008 Weekly monitoring of human cases of West Nile
Infection, Detection, and Protection: fever: an efficient way to assess the evolution of
Adventures in Epidemiology the disease in Europe
Co-Chairs: Philip Polgreen, USA L. Marrama Rakotoarivony, C. Bogaardt,
February 17, 2013

Tom Yuill, USA E. Robinson, V. Estevez, J. Jansa, H. Zeller,
D. Coulombier
Room: Klimt Ballroom 2&3 8:30–10:30 Stockholm (Sweden)
Upper Level Sunday, February 17, 2013
12.009 Determinants of active participation in internet-
12.001 Evaluation of cholera and other diarrheal diseases based surveillance systems
surveillance system, Niger State, Nigeria, 2012 D. Paolotti, P. Bajardi
•
SUNDAY

A.T. Bashorun1, A. Ahumibe1, S. Olugbon1, Turin (Italy)
A. Taju1, P. Nguku1, K. Sabitu2 12.010 An investigation of Salmonella enteritidis PT1
1
Abuja (Nigeria), 2Zaria (Nigeria) cases linked to consumption of a pasteurized
12.002 Surveillance during Hajj: Patterns and causes of liquid egg white product in England and
mortality amongst Indonesian pilgrims Wales, 2012
M. Pane1, S. Imari1, N. Kandun1, G. Samaan2 O. Esan, C. Lane, T. Peters
1
Jakarta (Indonesia), 2Canberra, ACT (Australia) London (United Kingdom)
12.003 ECDC/EpiNorth epidemic intelligence activities 12.011 Effects of climate change on the distribution of
during EURO 2012 in Poland and Ukraine bluetongue and epizootichaemorrhagic disease
A. M. Gherasim1, I. Linina2, G. Rimseliene3, vector in Southern Alberta (Canada) and
L. Paine Hallström1, J. Mantero1, P. Penttinen4 Montana(USA)
1
Stockholm (Sweden), 2Brussels (Belgium), A. Zuliani1, A. Massolo1, S. Marshall1, T. J. Lysyk2,
3
Oslo (Norway), 4Stockhokm (Sweden) G. Johnson3, S. Cork1
12.004 Improving capacity to investigate and respond to 1
Calgary, AB (Canada), 2Lethbridge, AB (Canada),
emerging infectious disease outbreaks in East and 3
Bozeman, MT (USA)
Central Africa
H. M. Amuguni1, T. Odoch2, R. Nauma2
1
North Grafton, MA (USA), 2Kampala (Uganda)

12
IMED 2013


Coffee Break Session 15
Ground Level 10:30–11:00 Panel Discussion
and Upper Level Sunday, February 17, 2013 Updates from ProMED
Co-Chairs: Stephen Morse, USA
Eskild Petersen, Denmark
Session 13
Plenar y Lecture Room: Klimt Ballroom 2&3 14:30–16:00
Global Approach to the Control of
Introduction
Foot and Mouth Disease
L. Madoff
Chair: Jacques Acar, France Boston, MA (USA)
Room: Park Congress 11:00–11:45 15.001 Novel coronavirus in the Eastern Mediterranean
Ground Level Sunday, February 17, 2013 M. Pollack
New York, NY (USA)
13.001 Global approach to the control of foot
and mouth disease 15.002 Continuing global emergence of dengue
B.Vallat S. Chotivichien1, Q. Nguyen1, J.Torres3
Paris (France)
1
Bangkok (Thailand), 2Hanoi (Vietnam). 3Caracas
(Venezuela).
15.003 Fungal meningitis outbreak
Poster Presentations II (Session 22) L. Lutwick
New York, NY (USA)
Sunday, February 17, 2013 11:45–13:15
15.004 Yellow fever in Darfur, Sudan
Bruckner/Mahler/Brahms - Upper Level J. Woodall1, T.Yuill2
and Klimt Ballroom - Upper Level 1
Rio de Janeiro (Brazil), 2Mapleton, UT (USA)
Sessions 22.001–22.185 (see pages 127–190)

Coffee Break
Session 14

SUNDAY
Ground Level 16:00–16:30
Cutting Edge Diagnostics for the and Upper Level Sunday, February 17, 2013
Detection of Novel and Neglected
Diseases

•
Session 16

February 17, 2013
Co-Chairs: Giuseppe Cornaglia, Italy
Keith Klugman, USA Disease Surveillance
Co-Chairs: John Brownstein, USA
Room: Park Congress 14:30–16:00 Ann Marie Kimball, USA
Ground Level Sunday, February 17, 2013
14.001 MALDI-TOF MS beyond bacterial and fungal Ground Level Sunday, February 17, 2013
identification
J.Vila 16.001 Integrating data mining and crowd-sourcing for
Barcelona (Spain) disease surveillance
14.002 Next generation sequencing in clinical J. Brownstein
microbiology diagnosis, what have we Boston, MA (USA)
achieved so far? 16.002 Participatory epidemiology:putting the public in
J.Van Eldere public health surveillance
Louvain (Belgium) M. Smolinski
14.003 Detection of emerging antimicrobial threats in San Francisco, CA (USA)
developing countries 16.003 Towards synergy between surveillance systems
K. Klugman for Epidemic Intelligence.
Atlanta, GA (USA) L.Vaillant
Saint Maurice (France)
Co-sponsored by ESCMID

13
IMED 2013


Session 17 17.006 Spotted fever group Rickettsia species
and Anaplasma phagocytophilum in lizards
Oral Presentations ticks, Algeria
Hot Topics H. Soualah-Alila1, Z. Bouslama2
1
Annaba, AL-AN (Algeria), 2Annaba (Algeria)
Co-Chairs: Daniel Beltrán-Alcrudo, Italy
Larry Lutwick, USA 17.007 Sequelae of human Cryptosporidiosis in
patients living in Östersund during a large
waterborne outbreak
J. Lindh1, A. Wallensten1, J. Bergstrom1,
17.001 Anthrax pleural effusions and drainage M. Lilja2, M. Widerstrom2
1979–2011: A Russia-USA partnership study.
1
Solna (Sweden), 2Östersund (Sweden)
D. Lucey1, L. Grinberg2, F. Abramova2 17.008 Evolution of gonococcal strain
1
Washington, DC (USA), 2Yekaterinburg (Russian susceptibility to antibiotics in France:
Federation) data from a national sentinel surveillance
17.002 Schmallenberg virus—Harmonized European network, 2001–2012
data collection for an emerging disease G. La Ruche1, P. Sednaoui2, B. Bercot2,
A. Afonso1, F. Berthe1, K. Willgert2, D. Verloo1, E. Cambau2, A. Goubard2
J. Cortinas Abrahantes1, A. Bau1, J. Richardson1
1
Saint-Maurice (France), 2Paris (France)
1
Parma (Italy), 2London (United Kingdom)
17.003 No evidence for zoonotic transmission of
Schmallenberg virus in areas with veterinary
activity
C. Reusken1, C. van den Wijngaard1, M. Beer2,
R. Bouwstra3, H. van den Kerkhof1,
W. van der Poel3, J. Schmidt-Chanasit4,
P. Vellema5, I. Wouters6, M. Koopmans7
1
Bilthoven (Netherlands), 2Greifswald-Insel Riems
(Germany), 3Lelystad (Netherlands), 4Hamburg
(Germany), 5Deventer (Netherlands), 6Utrecht
February 17, 2013

(Netherlands), 7Rotterdam (Netherlands)
17.004 The interaction of the spike glycoproteins of
bat-borne SARS-like-CoVs with chiropteran cells
during the entry process
M. Hoffmann, N. Krüger
Hanover (Germany)
•
SUNDAY

17.005 Tick species and tick-borne viruses of Eastern
cancelled
and North Eastern parts of Kenya: Health risk
implications among pastoral communities
J. Mutisya1, J. Lutomiah1, L. Musila1, S. Khamadi1,
H. Koka1, E. Chepkorir1, A. Makio1, J. Bast2,
E. Wurapa1, R. Sang1 Mayor’s Reception
1
Nairobi (Kenya), 2Kisumu (Kenya)
Sunday, February 17, 2013 20:00–22:00
Vienna City Hall (Entrance: Lichtenfelsgasse)
- no transportation provided

14
IMED 2013

S cientific Program MONDAY • FEBRUARY 18, 2013

Session 18 Coffee Break
Economics of Emerging Ground Level 10:30–11:00
Infectious Diseases and Upper Level Monday, February 18, 2013
Co-Chairs: Nilufar Rakhmanova, USA
David Fisman, Canada
Session 20
Ground Level Monday, February 18, 2013 Plenar y Lecture
18.001 Emerging infections and poverty: Big Data, Industry and Disease
Lessons from the Americas Surveillance
L. Ivers Chair: Larry Madoff, USA
Boston, MA (USA)
18.002 Vaccination choices and their impact on
Ground Level Monday, February 18, 2013
immunization programmes
P. Manfredi 20.001 Big data, industry and disease surveillance
Pisa (Italy) A. Signorini
18.003 Externalities, transaction costs and infectious Iowa City, IA (USA)
diseases
P. Polgreen
Iowa City, IA (USA)
18.004 Is it cost-effective? Best practices on evaluating
the bang-for-the-buck in communicable
disease control
D. Fisman
Toronto (Canada)

Session 19
Diseases Without Borders
Co-Chairs: Adriano Duse, South Africa
Benson Estambale, Kenya
Upper Level Monday, February 18, 2013

19.001 Hepatitis E outbreak at a refugee camp
J. Ahmed
Nairobi (Kenya)
19.002 Dynamics of the Uganda Ebola outbreak
A. Duse
Johannesburg (South Africa)
19.003 From surveillance to prevention: developing
MONDAY

a risk assessment framework for “novel”
emerging infections
S. Morse
•

New York, NY, and Davis, CA (USA)
February 18, 2013

19.004 NDM-1 and the international spread of
antibiotic resistance
M.Toleman
Cardiff, (United Kingdom)

15
IMED 2013

Poster Presentations I SATURDAY • FEBRUARY 16, 2013

Session 21 21.009 Are the neurological rehabilitation wards at
higher risk for multi-drug resistant micro-
Poster Presentations I organisms infections? A retrospective analysis
Saturday, February 16, 2013 11:45–13:15 from a rehabilitation center in Northern Italy
Bruckner/Mahler/Brahms • Upper Level focusing on clinical risk factors
M. Riccò1, D. Nicolotti2, C. Signorelli1, P. Camia1,
Antimicrobial Resistance S. Cattani1, V. Ciorba1, F. Pezzetti1, H. Cerrel Bazo2
1
Parma (Italy), 2Piacenza (Italy)
21.001 Ertapenem-resistance in Klebsiella pneumoniae
isolates from Croatia 21.010 Successful management of nosocomial
B. Bedenic1, M. Barisic1, Z. Bosnjak1, J. Vranes1, ventriculitis and meningitis caused by extensive
V. Plecko1, D. Varda-Brkic1, S. Sardelic2 drug resistant Acinetobacter baumannii, Austria
1
Zagreb (Croatia), 2Split (Croatia) M. Drescher, M. Hoenigl, G. Feierl, T. Valentin,
K. Seeber, E. Leitner, G. Zarfel, W. Duettmann,
21.002 Importance of clonal properties in addition R. Krause, A. J. Grisold
to antibiotic consumption in determining the Graz (Austria)
differences between macrolide resistant and
susceptible Streptococcus pyogenes 21.011 Antimicrobial resistance of human Salmonella
serovar Typhimurium U302 strains in Slovakia:
February 16, 2013

C. Silva-Costa, A. Friães, M. Ramirez,
J. Melo-Cristino, P. Portuguese Group for prevalence of R-type ASSuT
the Study of Streptococcal Infections L. Majtanova, V. Majtan
Lisbon (Portugal) Bratislava (Slovakia)

21.003 Carbapenem resistance of Pseudomonas 21.012 Inducuble clindamycin resistance in methicillin-
aeruginosa and Acinetobacter baumannii strains susceptible and methicillin-resistant Staphylococcus
•

in the intensive care unit in Romania aureus of inpatient, outpatient and healthy
SATURDAY

S. L. Pandrea, L. Matros, M. I. Ciontea carriers
Cluj (Romania), S. Uzunovi1, A. Ibrahimagi1, F. Kamberovi2,
M. Kunarac1, M. I. A. Rijnders3, E. E. Stobberingh3
21.004 Antibiotic resistance of Pseudomonas aeruginosa 1
Zenica (Bosnia and Herzegovina), 2Ljubljana
strains isolated from nosocomial infections in (Slovenia), 3Mastricht (Netherlands)
Romania
S. L. Pandrea, L. Matros, M. I. Ciontea 21.013 Serotype and clindamycin-resistance of
Cluj (Romania) Streptococcus suis in diseased pigs and
humans in upper northeast Thailand
21.005 Antimicrobial resistance of gram-negative bacilli S. Angkititrakul1, T. C. Nutravong2
causing infections in intensive care units in 1
Khon Kaen (Thailand), 2Khon Kaen, (Thailand)
Makkah hospitals, Saudi Arabia
A. Asghar 21.014 Escherichia coli B2 and D virulent phylotypes
Makkah (Saudi Arabia) carry extended-spectrum and pAmpC
betalactamases in healthy dogs with no
21.006 Inhibitory effects of Lactobacillus plantarum antimicrobial pressure
and Lactobacillus rahmnosus on the growth of A. Belas, N. Couto, C. Pomba
Pseudomonas aeruginosa Lisbon (Portugal)
S. Aminnezhad, K. Kermanshahi, R. Ranjbar, O.
Baghery 21.015 Antimicrobial resistance of Salmonella stanley
Tehran (Iran, Islamic Republic of) isolated from pigs, dogs and humans in
northeast of Thailand
21.007 Infection due to colistin-resistant Enterobacteriacae: A. Polpakdee, S. Angkititrakul
A single tertiary centre experience in critically ill Khon Kaen (Thailand)
patients from Saudi Arabia
M. A. Garbati1, A. Bin Abdulhak2, A. I. AlGodair3, 21.016 Analysis of the plasmid profile in Salmonella
H. Sakkijha1 typhimurium strains isolated in the Republic of
1
Riyadh, Riyadh (Saudi Arabia), 2Kansas City, MO Uzbekistan
(USA) L.Tuychiev, G. Abdukhalilova, A. Ibragimov,
I. Akhmedov
21.008 Infection with Escherichia coli and antimicrobial Tashkent (Uzbekistan)
susceptibility
I. Zurak 21.017 Characterization of uropathogenic E. coli and
Zagreb (Croatia) detection their ESBL TEM and SHV genes
S. N. El-Sukhon
Irbid (Jordan)

16
IMED 2013

Poster Presentations I SATURDAY • FEBRUARY 16, 2013

21.018 Copper alloys beneficial effects on ICU operation 21.027 Antibiotic resistant urinary tract infections and
P Efstathiou, E. Doe Kouskouni, S. Papanikolaou,
. Zataria multifolora Boiss: can it help us?
K. Karageorgou, Z. Manolidou, M. Tseroni2 Z. Sepehri1, F. Javadian1, E. Javadian2, O. Aloosh3,
E. Logothetis, I. Agrafa M. Mohammadi1, N. Keikhaee4, F. Rakhshani5
Athens (Greece), 1
Zabol (Iran, Islamic Republic of), 2Zahedan
21.019 Prevalence of drug-resistant tuberculosis in rural (Iran, Islamic Republic of), 3Hamedan (Iran, Islamic
eastern China Republic of), 4Mashhad (Iran, Islamic Republic of),
Q. Zhao, Y. Hu, W. Wang, W. Jiang, T. Tao, B. Xu
5
Tehran (Iran, Islamic Republic of)
Shanghai (China) 21.028 Resistance phenotypes of Staphylococcus aureus
21.020 Minced meat as a source for MRSA and strains isolated from intensive care unit in
ESBL-producing E. coli Romania
C. Petternel, J. Posch, D. Haas, H. Galler, G. Zarfel, S. L. Pandrea1, L. Matros2, M. I. Ciontea1
V. Strenger, E. Marth, F. Reinthaler, G. Feierl
1
Cluj-Napoca (Romania), 2Cluj (Romania)
Graz (Austria) 21.029 Evaluation of in-vitro anti-mycobacterial activity
21.021 Prevalence of commensal ESBL-producing of some Indian medicinal plants: Isolation of active
Escherichia coli strains isolated from piglets from constituents from Urtica dioica L. and Cassia
sophera (Linn.) Roxb.

SATURDAY
birth to nursery on three Portuguese industrial
pig farms. S. H. Kelam
M. M. Centeno1, N. Couto1, A. Belas1, T. Nunes1, Jhansi (India)
V. Almeida1, L. Alban2, C. Pomba1 21.030 Antibiotic resistance of uropathogens from

•
1
Lisbon (Portugal), 2Kobenhavn (Denmark) cancelled community-acquired urinary tract infections in

February 16, 2013
21.022 Relative activity over time of chlorhexidine and Besat University Hospital in Tehran, Iran in 2011
benzalkonium chloride against methicillin-resistant A. A. Saeedi, M. Aminianfar, E. Soleimani,
staphylococci isolates from horses M. Darvishi, S. Faraji
N. Couto1, A. Belas1, P. Tilley1, L. Telo da Gama1, Tehran (Iran, Islamic Republic of)
I. Couto1, K. Kadlec2, S. Schwarz2, C. Pomba1 21.031 Antimicrobial resistance surveillance of
1
Lisbon (Portugal), 2Neustadt-Mariensee (Germany) baumannii isolated from Besat
cancelled Acinetobacter
21.023 Detection of bacteria resistant to critically University Hospital in Tehran, Iran from 2009
important antimicrobials from lower urinary to 2011
tract infections in cats and dogs from Portugal A. A. Saeedi, S. Faraji, F. Rahimi, M. Aminianfar,
C. Pomba, D. Saial, M. M. Centeno, A. Belas, M. Khosravi, E. Soleimani, M. Darvishi
N. Couto Tehran (Iran, Islamic Republic of)
Lisbon (Portugal) 21.032 Occurrence of plasmid-mediated enrofloxacin
21.024 Trends in the prevalence of methicillin resistance and tetracycline resistance determinants, among
in staphylococci isolated from companion animals Escherichia coli isolated from lambs in Greece
N. Couto, A. Belas, M. M. Centeno, C. Pomba G. Filioussis1, E. Petridou1, A. Tzivara2, S. Kritas1
Lisbon (Portugal)
1
Thessaloniki (Greece), 2Karditsa Thessaly
(Greece)
21.025 Isolation and characterization of anti-Pythium
insidiosum compounds from Pseudomonas stutzeri Bioterrorism and Biological Warfare
isolated from aquatic environment
21.033 A guide to the diagnosis and management
Y.Thongsri1, C. Aromdee1, S. Kanokmedhakul1,
of CDC Category A bioterrorism agents
C. Yenjai1, A. Chaiprasert2, P. Hamal3,
(“Be Past”)
C. Prariyachatigul1
J.Varco, D. Lucey
1
Thailand, Khon Kaen (Thailand), 2Khon Kaen
Washington, DC (USA)
(Thailand), 2Bangkok, Thailand (Thailand),
3
Olomouc (Czech Republic) 21.034 Antimicrobial susceptibility and molecular
characteristics of Bacillus anthracis strains
21.026 Detection of extended-expectrum ß-lactamase
isolated in Slovenia
(ESBL) producing Enterobacteriaceae in organic
M. Ocepek1, I. Zdovc1, S. Duvnjak2, U. Zajc1,
bovine milk
T. Pirš1, M. Pate1, M. Golob1, S. Spicic2, I. Racic2,
A. K. Siqueira1, M. M. G. Ferraz1, T. Salerno2,
Z. Cvetnic2
G. H. B. Lara2, F. J. P. Listoni2, C. Lambertini1, 1
Ljubljana (Slovenia), 2Zagreb (Croatia)
A. V. da Silva3, A. C. Paes2, M. G. Ribeiro2,
D. D. S. Leite1
1
Campinas, SP (Brazil), 2São Paulo, SP (Brazil),
3
Feira de Santana,(Brazil)
17
IMED 2013

Imed 2013

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (19)

Andere mochten auch

Andere mochten auch (9)

Ähnlich wie Imed 2013

Ähnlich wie Imed 2013 (20)

Mehr von Irene Susilo

Mehr von Irene Susilo (20)

Imed 2013